michigan glp-1 diarrhea class action receptor agonists—the of drugs behind Ozempic, Wegovy, and Mounjaro—may do more than regulate blood sugar and weight. ⁠ ⁠ In an analysis of more than 6,800 colon cancer patients across Opinion | GLP-1 Experimentation Is

2023;60(8):2143-2152

Carey MD Krieger School of Arts and Sciences, Johns Hopkins University, Baltimore

A real-world study presented at ECO 2025 shows members in Emblas digital program achieved the same weight loss as seen in semaglutide trials with significantly lower doses of the drug.

I was a little nauseous for the first two days, but by the end of week 1, I felt better AND I had lost about 2 lbs

Conclusions Twenty-four weeks of acarbose monotherapy in newly diagnosed patients with T2D is associated with significantly increased levels of both fasting and postprandial GLP-1 as well as significantly increased NO levels and NOS activity for those patients in whom postprandial GLP-1 levels were increased